Company / Free Cash Flow
Amgen Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$8.1B
FY2025
5-year range
$7.4B / $10.4B
FY2021-FY2025
Trend
-22.1%
vs FY2024
Sector context
#7 of 192
Health Care
What the data says
Among 192 Health Care companies, Amgen is in the top 4% for free cash flow. Free Cash Flow has fluctuated over the past 10 years, ranging from $7.4B in FY2023 to $10.6B in FY2018.
Based on SEC 10-K filings.
$8.1B in FY2025 with a 5-year CAGR of -3.9%. Top quartile in the Health Care sector.
Improved from $7.4B to $8.1B over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -2.7%
- 5-Year CAGR
- -3.9%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 192This company $8.1B Sector average $474.2M
▼
+1608.3% above sector average
Key checks
Key Insights
- 5-year CAGR of -3.9%, indicating a declining trend.
- In FY2025, free cash flow decreased 22.1% year-over-year.
- Ranks #7 out of 192 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.1B | -22.1% |
| FY2024 | $10.4B | +41.2% |
| FY2023 | $7.4B | -16.2% |
| FY2022 | $8.8B | +4.8% |
| FY2021 | $8.4B | -15.2% |
| FY2020 | $9.9B | +15.9% |
| FY2019 | $8.5B | -19.2% |
| FY2018 | $10.6B | +0.4% |
| FY2017 | $10.5B | +9.3% |
| FY2016 | $9.6B | +5.2% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026